Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Guerineau H,Cayuela J,Dulucq S,Tran Quang V,Tarfi S,Gricourt G,Barathon Q,Joy C,Wagner-Ballon O,Morisset S,Nicolini F,Brunet E,Maury S,Roy L,Etienne G,Réa D,Sloma I

Source :

Pmid / DOI: